Medifron DBT Co Ltd
KOSDAQ:065650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pamel Yenilenebilir Elektrik Uretim AS
IST:PAMEL.E
|
TR |
|
Liberty Media Corp
NASDAQ:LSXMA
|
US |
|
A
|
Axion Ventures Inc
OTC:AXNVF
|
CA |
|
P
|
PCL Technologies Inc
TWSE:4977
|
TW |
|
C
|
Contact Energy Ltd
ASX:CEN
|
NZ |
|
Biosig Technologies Inc
NASDAQ:BSGM
|
US |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
M
|
Medifron DBT Co Ltd
KOSDAQ:065650
|
25.7B KRW |
Loading...
|
|
| JP |
D
|
Daiwa Tsushin Co Ltd
TSE:7116
|
2.7T JPY |
Loading...
|
|
| ZA |
D
|
Datatec Ltd
JSE:DTC
|
15.9B ZAR |
Loading...
|
|
| US |
|
CDW Corp
NASDAQ:CDW
|
15.3B USD |
Loading...
|
|
| US |
|
TD Synnex Corp
NYSE:SNX
|
12.6B USD |
Loading...
|
|
| CN |
|
Unisplendour Corp Ltd
SZSE:000938
|
71.9B CNY |
Loading...
|
|
| TW |
|
WT Microelectronics Co Ltd
TWSE:3036
|
289.8B TWD |
Loading...
|
|
| US |
|
Arrow Electronics Inc
NYSE:ARW
|
7.1B USD |
Loading...
|
|
| US |
|
Avnet Inc
NASDAQ:AVT
|
4.9B USD |
Loading...
|
|
| TW |
|
WPG Holdings Ltd
TWSE:3702
|
154.6B TWD |
Loading...
|
|
| JP |
|
Canon Marketing Japan Inc
TSE:8060
|
753.3B JPY |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Medifron DBT Co Ltd
Glance View
Medifron DBT Co., Ltd. engages in the provision of information technology (IT) content services. The company is headquartered in Seoul, Seoul and currently employs 55 full-time employees. The company went IPO on 2003-01-21. The firm operates its business through two segments. The Information Technology Business segment is involved in the manufacturing and sale of mouses, monitors, televisions (TVs), routers and game devices. In addition, it is involved in the operation of Internet portals and specialized sites. The New Drug Business segment is engaged in the development and sale of non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Medifron DBT Co Ltd is 14.2%, which is above its 3-year median of 12.2%.
Over the last 3 years, Medifron DBT Co Ltd’s Gross Margin has decreased from 18.4% to 14.2%. During this period, it reached a low of 7.4% on Mar 31, 2025 and a high of 18.4% on Sep 30, 2022.
